Notably, 79% of patients (15 out of 19) who were T790M-positive before transformation lost T790M at the time of SCLC emergence, suggesting both a loss of EGFR dependency and potential resistance to subsequent EGFR-TKI therapy. The gene discussed is EGFR; the disease is small cell lung carcinoma.